ADC/AOC CRO
We are committed to empowering the R&D of novel ADC/AOC therapeutics with comprehensive, efficient and customized technical support. Our core service portfolio includes: target linker design & synthesis, site-specific conjugation technology, process optimization, rigorous analytical characterization, stability testing. We leverage mature, standardized technical platforms and advanced analytical tools to ensure controllable DAR (Drug-Antibody Ratio), high conjugate purity, excellent batch consistency and reliable product quality.
